G6PD and G6PD deficiency: Despite the recommendation for G6PD normal individuals, patients were not treated with primaquine because of a relatively high prevalence of G6PD deficiency of 8–19% [18–21], a lack of PoC G6PD testing [15], and concerns about severe hemolysis following drug exposure [15].